Gordana Posilovic-Zivanovic
Zagreb, 10000, Croatia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 30, 2025
Stable Gastric Pentadecapeptide BPC 157 Therapy for Monocrotaline-Induced Pulmonary Hypertension in Rats Leads to Prevention and Reversal.
Journal: Biomedicines
Published: May 14, 2021
In relation to NO-System, Stable Pentadecapeptide BPC 157 Counteracts Lidocaine-Induced Adverse Effects in Rats and Depolarisation In Vitro.
Journal: Emergency medicine international
Published: March 04, 2020
BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats.
Journal: Life sciences
Published: January 05, 2017
Stable gastric pentadecapeptide BPC 157 and bupivacaine.
Journal: European journal of pharmacology
Published: August 24, 2016
BPC 157: The counteraction of succinylcholine, hyperkalemia, and arrhythmias.
Journal: European journal of pharmacology
Published: February 01, 2016
Duodenocutaneous fistula in rats as a model for "wound healing-therapy" in ulcer healing: the effect of pentadecapeptide BPC 157, L-nitro-arginine methyl ester and L-arginine.
Journal: Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
Published: January 11, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026